Dr. Reem Eltanahy is the Manager of Biologics Variation Unit at the Egyptian Drug Authority (EDA). With over 13 years of experience in the pharmaceutical and biologics industry, she has held various positions within the regulatory sector.

Dr. Eltanahy earned her Bachelor of Science in Pharmaceutical Sciences from Cairo University and a Master of Business Administration from the Arab Academy for Science, Technology, and Maritime Transport.

At the EDA, she leads her team in regulating post-approval changes to registered biological products. Notably, she played a key role in establishing “the guidelines for regulating post-approval changes to a registered bio-therapeutic product in Egypt.”

Furthermore, Dr. Eltanahy was part of the team that successfully achieved WHO GBT ML3 for vaccines at the EDA.